Mehdi Gasmi insider trades: Adverum Biotechnologies (ADVM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mehdi reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 20, 2020 | ADVM | ↓ Sell10b5-1 | 5,000 | $17.60 | $88K | Direct | Jul 22, 2020 (2d) |
| Jun 22, 2020 | ADVM | ↓ Sell10b5-1 | 23,605 | $25.06 | $592K | Direct | Jun 23, 2020 (1d) |
| Jun 18, 2020 | ADVM | ↓ Sell10b5-1 | 11,395 | $25.01 | $285K | Direct | Jun 18, 2020 (0d) |
| Jun 15, 2020 | ADVM | ↓ Sell10b5-1 | 10,000 | $21.86 | $219K | Direct | Jun 17, 2020 (2d) |
| May 21, 2020 | ADVM | ↓ Sell10b5-1 | 5,000 | $20.02 | $100K | Direct | May 22, 2020 (1d) |
| May 18, 2020 | ADVM | ↓ Sell10b5-1 | 40,000 | $18.85 | $754K | Direct | May 20, 2020 (2d) |
| Feb 18, 2020 | ADVM | ↓ Sell10b5-1 | 5,000 | $16.23 | $81K | Direct | Feb 20, 2020 (2d) |
| Feb 12, 2020 | ADVM | ↓ Sell10b5-1 | 10,000 | $15.07 | $151K | Direct | Feb 14, 2020 (2d) |
| Jun 15, 2015 | [AAVL] | ↓ Sell | 500 | $39.86 | $20K | Direct | Jun 17, 2015 (2d) |
| Jun 8, 2015 | [AAVL] | ↓ Sell | 500 | $38.64 | $19K | Direct | Jun 10, 2015 (2d) |
| May 28, 2015 | [AAVL] | ↓ Sell | 500 | $38.02 | $19K | Direct | May 29, 2015 (1d) |
| May 21, 2015 | AAVL | ↓ Sell | 500 | $38.87 | $19K | Direct | May 22, 2015 (1d) |
| May 14, 2015 | [AAVL] | ↓ Sell | 500 | $35.31 | $18K | Direct | May 15, 2015 (1d) |
| May 7, 2015 | AAVL | ↓ Sell | 500 | $33.28 | $17K | Direct | May 8, 2015 (1d) |
| Apr 28, 2015 | AAVL | ↓ Sell | 1,000 | $35.67 | $36K | Direct | Apr 30, 2015 (2d) |
| Apr 21, 2015 | AAVL | ↓ Sell | 1,000 | $39.21 | $39K | Direct | Apr 23, 2015 (2d) |
| Apr 14, 2015 | AAVL | ↓ Sell | 1,000 | $39.45 | $39K | Direct | Apr 15, 2015 (1d) |
| Apr 7, 2015 | AAVL | ↓ Sell | 9,000 | $38.60 | $347K | Direct | Apr 8, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADVM insiders
Open-market trades in the last 12 months
About Mehdi Gasmi's insider trades
Mehdi Gasmi is a director at Adverum Biotechnologies (ADVM). Since Apr 7, 2015, Mehdi has reported no open-market purchases and 18 sales worth $2.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
8 sales (80% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (18 filings), grants and awards (11 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADVM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.